Specialità Fine Chemicals was established in 2013, through an initiative of Prati-Donaduzzi Group, aiming at the development of the manufacturing process of Active Pharmaceutical Ingredients (APIs) considered strategic for the company's business. We started the work focused on some generic anticancer drug substances.

For the development of the manufacturing processes of these products, a state-of-the-art organic synthesis laboratory with a total of 250 square-meters built-up area has been structured and equipped in order to allow the synthesis of organic compounds from the scale of units of grams up to the scale of hundreds of grams.

Specialità's R&D team is highly qualified, and is responsible for both development of manufacturing processes, as well as for development and validation of analytical methods of APIs and raw materials used in its manufacturing processes. In 2015, the company started the development of manufacturing process of Cannabidiol API through chemical synthesis, reaching the product of interest with high purity content.